UBS AM’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.07B | Sell |
|
|||||
|
2025
Q2 | $1.37B | Buy |
|
|||||
|
2025
Q1 | $1.14B | Buy |
|
|||||
|
2024
Q4 | $968M | Buy |
|
|||||
|
2024
Q3 | $765M | Sell |
|
|||||
|
2024
Q2 | $731M | Buy |
|
|||||
|
2024
Q1 | $502M | Sell |
|
|||||
|
2023
Q4 | $459M | Buy |
|
|||||
|
2023
Q3 | $405M | Buy |
|
|||||
|
2023
Q2 | $362M | Hold |
|
|||||
|
2023
Q1 | $362M | Sell |
|
|||||
|
2022
Q4 | $377M | Buy |
|
|||||
|
2022
Q3 | $217M | Sell |
|
|||||
|
2022
Q2 | $211M | Sell |
|
|||||
|
2022
Q1 | $251M | Sell |
|
|||||
|
2021
Q4 | $242M | Sell |
|
|||||
|
2021
Q3 | $276M | Sell |
|
|||||
|
2021
Q2 | $287M | Sell |
|
|||||
|
2021
Q1 | $317M | Buy |
|
|||||
|
2020
Q4 | $278M | Buy |
|
|||||
|
2020
Q3 | $266M | Buy |
|
|||||
|
2020
Q2 | $236M | Buy |
|
|||||
|
2020
Q1 | $174M | Buy |
|
|||||
|
2019
Q4 | $201M | Buy |
|
|||||
|
2019
Q3 | $179M | Buy |
|
|||||
|
2019
Q2 | $179M | Sell |
|
|||||
|
2019
Q1 | $165M | Buy |
|
|||||
|
2018
Q4 | $151M | Buy |
|
|||||
|
2018
Q3 | $158M | Buy |
|
|||||
|
2018
Q2 | $134M | Sell |
|
|||||
|
2018
Q1 | $115M | Buy |
|
|||||
|
2017
Q4 | $91.8M | Buy |
|
|||||
|
2017
Q3 | $107M | Buy |
|
|||||
|
2017
Q2 | $99.9M | Buy |
|
|||||
|
2017
Q1 | $85.4M | Buy |
|
|||||
|
2016
Q4 | $68.1M | Sell |
|
|||||
|
2016
Q3 | $121M | Buy |
|
|||||
|
2016
Q2 | $94.9M | Buy |
|
|||||
|
2016
Q1 | $56.8M | Sell |
|
|||||
|
2015
Q4 | $56.8M | Sell |
|
|||||
|
2015
Q3 | $61.7M | Sell |
|
|||||
|
2015
Q2 | $73.7M | Buy |
|
|||||
|
2015
Q1 | $73.1M | Sell |
|
|||||
|
2014
Q4 | $59.5M | Buy |
|
|||||
|
2014
Q3 | $52.4M | Sell |
|
|||||
|
2014
Q2 | $57M | Buy |
|
|||||
|
2014
Q1 | $59.2M | Buy |
|
|||||
|
2013
Q4 | $50.3M | Buy |
|
|||||
|
2013
Q3 | $47.4M | Buy |
|
|||||
|
2013
Q2 | $37M | Buy |
|